A detailed history of Ubs Group Ag transactions in Immunocore Holdings PLC stock. As of the latest transaction made, Ubs Group Ag holds 43,719 shares of IMCR stock, worth $1.42 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
43,719
Previous 13,199 231.23%
Holding current value
$1.42 Million
Previous $447,000 204.25%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$30.06 - $41.49 $917,431 - $1.27 Million
30,520 Added 231.23%
43,719 $1.36 Million
Q2 2024

Aug 13, 2024

SELL
$33.78 - $63.75 $2,736 - $5,163
-81 Reduced 0.61%
13,199 $447,000
Q1 2024

May 13, 2024

BUY
$60.14 - $75.36 $719,935 - $902,134
11,971 Added 914.51%
13,280 $863,000
Q4 2023

Feb 09, 2024

SELL
$42.85 - $69.5 $7,241 - $11,745
-169 Reduced 11.43%
1,309 $89,000
Q3 2023

Nov 09, 2023

SELL
$49.5 - $66.6 $19,701 - $26,506
-398 Reduced 21.22%
1,478 $76,000
Q2 2023

Aug 11, 2023

BUY
$48.54 - $61.64 $10,727 - $13,622
221 Added 13.35%
1,876 $112,000
Q1 2023

May 12, 2023

SELL
$46.12 - $65.71 $225,711 - $321,584
-4,894 Reduced 74.73%
1,655 $81,000
Q4 2022

Feb 08, 2023

BUY
$45.51 - $65.08 $28,534 - $40,805
627 Added 10.59%
6,549 $373,000
Q3 2022

Nov 10, 2022

SELL
$37.34 - $57.44 $43,837 - $67,434
-1,174 Reduced 16.54%
5,922 $278,000
Q2 2022

Aug 10, 2022

SELL
$25.46 - $37.72 $33,403 - $49,488
-1,312 Reduced 15.6%
7,096 $265,000
Q1 2022

May 16, 2022

SELL
$18.94 - $34.29 $19,640 - $35,558
-1,037 Reduced 10.98%
8,408 $251,000
Q4 2021

Feb 14, 2022

SELL
$27.58 - $40.0 $125,654 - $182,240
-4,556 Reduced 32.54%
9,445 $323,000
Q3 2021

Nov 15, 2021

BUY
$27.98 - $40.0 $55,596 - $79,480
1,987 Added 16.54%
14,001 $519,000
Q2 2021

Aug 13, 2021

BUY
$32.22 - $41.5 $10,987 - $14,151
341 Added 2.92%
12,014 $469,000
Q1 2021

May 12, 2021

BUY
$36.3 - $56.34 $423,729 - $657,656
11,673 New
11,673 $497,000

Others Institutions Holding IMCR

About Immunocore Holdings plc


  • Ticker IMCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,897,100
  • Market Cap $1.42B
  • Description
  • Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...
More about IMCR
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.